Obtaining Real-World Disease, Demographic Data on Myelofibrosis
December 11th 2020Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about why data are limited in myelofibrosis.
Read More
Making Treatment Decisions for Patients with Myelofibrosis
December 10th 2020Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about factors in treatment decisions for patients with myelofibrosis.
Watch
Triple-Negative Breast Cancer: Improved Outcomes and Providing Patient-Centered Care
March 3rd 2020Melissa B. Armitage, PharmD, BCOP, a clinical pharmacist who works in breast oncology at the Moffitt Cancer Center in Tampa, Florida, discussed this disease's pathophysiology, natural progression, and risk factors.
Read More